skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
DEPDC1/MPHOSH1 Peptide Vaccine (Code C74023)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: DEPDC1/MPHOSH1 Peptide Vaccine

Definition: A cancer vaccine containing HLA-A*2402-restricted epitopes derived from DEP domain containing 1 (DEPDC1) and M phase phosphoprotein 1 (MPHOSPH1) with potential immunostimulatory and antineoplastic activities. Upon administration, DEPDC1/MPHOSH1 peptide vaccine may elicit a specific cytotoxic T lymphocyte (CTL) response against tumor cells expressing DEPDC1 and MPHOSPH1, tumor antigens that are overexpressed in bladder cancer cells.

Label: DEPDC1/MPHOSH1 Peptide Vaccine

NCI Thesaurus Code: C74023 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL383544  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
DEPDC1/MPHOSH1 Peptide Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 590659
PDQ Open Trial Search ID 590659 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C74023
Legacy_Concept_Name DEPDC1_MPHOSH1_Peptide_Vaccine
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom